We empower patients.
Clinical UMIPIC-Therapy:
Ultra Minimum Incision Personalized Intra-Tumoral Chemo-Immuno Therapy
Simplicity, superior efficacy, and minimal side effects make UMIPIC a groundbreaking treatment. This new intra-tumor treatment has been used in over 37,000 treatments over the past 20 years, with superior advantages and results as compared to other treatment therapies. As an immunological approach to cancer treatment, this therapy not only treats current tumors but can also teach your body to prevent future ones, allowing you to live a longer and better life. It’s simple, short and has virtually zero side effects
​
We believe that cancer patients deserve the best treatment. Scientific and clinical evidence indicates that UMIPIC-Therapy, which eradicates solid tumors and elicits cancer-fighting immune responses, can be that best treatment option for many patients. It can be a life saving therapy for those who have already tried traditional cancer treatment with little to no results. UMIPIC-Therapy can do what other treatments cannot. Dr. Baofa Yu, clinical oncologist, pioneered this treatment through extensive and rigorous postdoc studies in some of the finest research institutions in the world, including the Salk Institute and UCSD School of Medicine. His UMIPIC treatment shows significant advancement in treating advanced Stage III & IV solid cancer tumors and systemic metastases. UMIPIC can also be used in conjunction with, either before or after, conventional treatments (radiation, chemotherapy). You can read more about the clinical studies here.
​
Simple, cost-effective treatment
UMIPIC consists of, on average, three treatments. Each one is usually a 30-45-minute-long procedure and admninistered one week apart. It is a fraction of the cost of many immunotherapy treatments available today. This means more time and money to do what you love to do once your treatment is complete.
Clinically effective for a broad spectrum of tumors
Our studies have shown statistically significant increases in survival rate for patients with various kinds of solid state tumors including in the liver, lung, and pancreas. Note: no case is typical. You should not expect to experience these results.
Meet Dr. Baofa Yu
World-renowned Oncologist and developer of UMIPIC
Dr. Baofa Yu MD has opened 3 hospitals within 3 different cities in China, including Beijing, that specialize in treating solid tumors. He has developed the new intra-tumor treatment called UMIPIC - Ultra Minimum Incision Personalized Intra-Tumoral ChemoImmunology Therapy, which has been used to treat over 10,000 patients in over 15 years, with superior advantages and results.
